Product Information
CLOMIPRAMINE 50 MG CAPSULE is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2581 per EA under NDC 68180049301. Its NADAC has been published 392 times since Apr 3, 2019.
FDA first approved this application on Nov 21, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180049301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209294FDA Approved
11/21/2018
TE Code
AB
On Market Since
2/4/2019
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 50 MG CAPSULE has been published 392 times since Apr 3, 2019, and over the history we have for it it has declined 92.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2581 per EA |
|---|---|
| All-time high | $4.2239 (Feb 12, 2020) |
| All-time low | $0.2016 (May 22, 2024) |
| 52-week high | $0.2915 |
| 52-week low | $0.2257 |
| Median price | $0.4235 |
| Average price | $1.2260 |
| Largest weekly change | -56.5% (Nov 23, 2022) |
| Weeks tracked | 392 |
| Tracking since | Apr 3, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clomipramine Hydrochloride Capsules market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clomipramine Hydrochloride Capsules market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 50 MG CAPSULE, manufactured by Lupin Pharmaceuticals Inc., is $0.2581 per EA (NDC 68180049301), effective Sep 30, 2026.
How has the price of CLOMIPRAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has declined 92.3%. It has been tracked across 392 weekly CMS publications since Apr 3, 2019.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 50 MG CAPSULE?
Since Apr 3, 2019, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has ranged from a low of $0.2016 (May 22, 2024) to a high of $4.2239 (Feb 12, 2020), with a median of $0.4235 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 50 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of CLOMIPRAMINE 50 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLOMIPRAMINE 50 MG CAPSULE?
CLOMIPRAMINE 50 MG CAPSULE (NDC 68180049301) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.